Disease-modifying drugs have mostly failed as treatments for progressive multiple sclerosis.
Management of the disease therefore solely aims to minimise symptoms and, if possible …

Fatigue is one of the most common symptoms of multiple sclerosis. Despite advances in
pharmacological and non-pharmacological treatment, fatigue continues to be the disabling …

Background People with functional neurological disorder (FND) are commonly seen by
occupational therapists; however, there are limited descriptions in the literature about the …

Opinion statement Multiple sclerosis (MS) is an inflammatory-demyelinating disease of the
central nervous system that may entail severe levels of disability in the long term. However …

Objective To evaluate the efficacy of a telephone-delivered self-management intervention for
fatigue, pain, and depression in adults with multiple sclerosis (MS). Design Single-center …

Background Fatigue is a frequently occurring symptom of multiple sclerosis (MS) that limits
social participation. Objective To systematically determine the short and long-term effects of …

Multiple sclerosis (MS) is a neuroinflammatory condition with a prominent progressive
neurodegenerative facet that typically affects young‐or middle‐aged adults. Although …

Fatigue is a common and highly debilitating symptom of multiple sclerosis (MS). This meta-
analytic systematic review with detailed narrative synthesis examined randomised …

Background: Fatigue is a common, debilitating symptom of multiple sclerosis (MS) without a
current standardised treatment. Objective: The aim of this systematic review with network …

Objectives To see if a group course delivered by rheumatology teams using cognitive-
behavioural approaches, plus usual care, reduced RA fatigue impact more than usual care …